Nikolaus F. Kienzl
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters.
Journal: Scientific reports
Published: January 28, 2025
Author Correction: Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level.
Journal: Nature communications
Published: February 28, 2023
Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level.
Journal: Nature communications
Published: June 17, 2022
Designed SARS-CoV-2 receptor binding domain variants form stable monomers.
Journal: Biotechnology journal
Published: August 08, 2021
Impact of Specific N-Glycan Modifications on the Use of Plant-Produced SARS-CoV-2 Antigens in Serological Assays.
Journal: Frontiers in plant science
Published: July 26, 2021
Peroxidasin protein expression and enzymatic activity in metastatic melanoma cell lines are associated with invasive potential.
Journal: Redox biology
Published: July 20, 2021
N-Glycosylation of the SARS-CoV-2 Receptor Binding Domain Is Important for Functional Expression in Plants.
Journal: Frontiers in plant science
Published: March 31, 2021
Generation of enzymatically competent SARS-CoV-2 decoy receptor ACE2-Fc in glycoengineered Nicotiana benthamiana.
Journal: Biotechnology journal
Published: November 03, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026